Chiara Gulisano

Dr. Chiara Gulisano


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2025 in Diabetology
Verified
Journal Article
Open access
PDF file
AMAngelo Milioto
Angelo Milioto
CGChiara Gulisano
Chiara Gulisano
GSGiordano Spacco
Giordano Spacco
GSGiulia Siri
Giulia Siri
BCBenedetta Caccia
Benedetta Caccia
FCFrancesco Cocchiara
Francesco Cocchiara
Background/Objectives: Hormonal fluctuations during the menstrual cycle can affect glycemic control in women with type 1 diabetes (T1D), especially during the luteal phase, when increased insulin resistance may lead to prolonged hyperglycemia. Advanced Hybrid Closed-Loop (AHCL) systems could help manage these hormone-driven fluctuations. This study aimed to assess glycemic control across menstrual phases and explore the role of AHCL systems in counteracting the related glucose variability. Methods: A retrospective study was conducted including women with T1D and regular menstrual cycles (study group) and women on estroprogestin therapy (control group). Each group was subdivided by insulin delivery method (AHCL vs. non-AHCL). Glycemic metrics and insulin requirements were compared between the follicular and luteal phases, and between groups. Results: The study included 94 women (62 in the study group, 32 in the control group). In the study group, glycemic control worsened during the luteal phase, with increased average glucose, glycemic variability, and time above range > 250 mg/dL (+0.93%, p = 0.03) and reduced time in range 70–180 mg/dL. These changes were more pronounced among AHCL users, who also showed a significant increase in bolus insulin. No phase-related differences were observed in the control group or among non-AHCL users. Significantly higher insulin needs during the follicular phase were found in the study group compared with the controls. Conclusions: This study confirmed a worsening in glycemic control in women affected by T1D during the luteal phase of the menstrual cycle, suggesting a need for more tailored management. The clear efficacy of AHCL systems in counteracting hormone-related glycemic fluctuations has not been proved, highlighting the need for further research in larger, more homogeneous cohorts.

18 April 2023 in Heliyon
Verified
Journal Article
Open access
RFRaffaele Falsaperla
Raffaele Falsaperla
CGChiara Gulisano
Chiara Gulisano
LPLaura Portale
Laura Portale
AMAmanda Maccarrone
Amanda Maccarrone
MRMartino Ruggieri
Martino Ruggieri
The aim of our study was to assess the close direct relationship between the development of neurological manifestations and SARS-CoV-2 infection in paediatric patients, by a systematic review of the literature. PubMed and Google Scholar were searched for publications from the start of the pandemic up to 31 December 2022. We included articles that described nervous system manifestations in patients aged 0–18 years with RT-PCR nasopharyngeal swab positivity for SARS-CoV-2. The initial search produced 3456 records, of which 37, involving a total of 48 paediatric patients, were included in our systematic review. The neurological complications were heterogeneous, due at least in part to the different age groups considered. In the literature, encephalitis was the most common diagnosis (20.83%). Clinical presentation, diagnostic support, treatment and outcome were analysed both in the literature and in our experience. Neurological impairment can occur with the first clinical presentation of COVID-19, even in previously healthy children and with mild forms of the disease. The clinical presentations are heterogeneous in the different age groups. In most patients the outcome is good and neurological manifestations subside after discharge.

18 February 2026 in Medico e Bambino Pagine Elettroniche
Verified
Journal Article
Closed access
CGChiara Gulisano
Chiara Gulisano
FLFrancesca Lugani
Francesca Lugani
EBElena De Benedetti
Elena De Benedetti
DCDecimo Silvio Chiarenza
Decimo Silvio Chiarenza
EVEnrico Eugenio Verrina
Enrico Eugenio Verrina
A 20-month-old boy with severe growth failure and Fanconi syndrome was diagnosed with nephropathic cystinosis, confirmed by corneal deposits and CTNS gene analysis. Despite septic complications, cysteamine therapy successfully stabilised his condition. The case illustrates diagnostic challenges in humanitarian crisis settings and the vital importance of prompt intervention.

11 October 2024 in Medico e Bambino Pagine Elettroniche
Verified
Journal Article
Closed access
CGChiara Gulisano
Chiara Gulisano
CMCamilla Marazzi
Camilla Marazzi
MBMarta Bassi
Marta Bassi
GTGiacomo Tantari
Giacomo Tantari
GDGiuseppe D'ANnunzio
Giuseppe D'ANnunzio
NMNicola Minuto
Nicola Minuto
A 15-year-old girl presented with diabetes mellitus without ketoacidosis, initially treated as type 1 diabetes (T1DM). Despite a family history of diabetes, the patient showed reduced insulin requirements (0.3 U/kg/day) and tested negative for autoantibodies associated with T1DM. Following ISPAD guidelines, genetic testing was performed, revealing a heterozygous mutation in the HNF4α gene, associated with MODY 1 (Maturity-Onset Diabetes of the Young). The patient maintained good glycemic control with insulin therapy, but the case raises questions about the timing and approach to transitioning to sulfonylureas, the first-line treatment for MODY 1, which could potentially improve glycemic control and the quality of life.